Page 21 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 21

Page 8 of 16  Guideline


              Maintenance phase (secondary prophylaxis)             If there is renal impairment at baseline with a creatinine
              The panel recommends fluconazole 200 mg daily for at least   clearance of < 30 mL/min or a deterioration in renal function,
              10 more months (i.e. to complete a total of 12 months of   the recommended induction regimens are the following:
              antifungal treatment). Maintenance fluconazole should only   •  If liposomal amphotericin B is available, 1 week of
              be  stopped  when the  CD4  count  is documented  to  be   liposomal amphotericin B (3 mg/kg/day – 4 mg/kg/day)
              > 200 cells/µL (on one occasion is sufficient) and the most   and flucytosine, followed by 1 week of fluconazole (both
              recent HIV viral load is suppressed.                    fluconazole  and  flucytosine  dose  adjusted  according  to
                                                                      creatinine clearance).
              Adolescents and children                              •  Two  weeks  of fluconazole  (dose  adjusted  according  to
              During the induction phase, amphotericin B should be    creatinine clearance) and flucytosine (dose adjusted
              prescribed at a daily dose of 1 mg/kg/day and flucytosine as   according to creatinine clearance).
              a (divided)  daily dose  of 100 mg/kg/day  (Table 5).   •  If neither flucytosine nor  liposomal amphotericin  B is
              Fluconazole doses should also be calculated by body weight:   available,  administer a single  dose of amphotericin  B
              induction phase: 12 mg/kg/day (up to 800 mg daily);     deoxycholate (0.7 mg/kg) and daily fluconazole (dose
              consolidation phase: 6 mg/kg/day – 12 mg/kg/day (up to   adjusted according to creatinine clearance) and monitor
              800 mg daily); and maintenance phase: 6 mg/kg/day (up to   creatinine clearance daily.  Administer amphotericin B
              200 mg daily).                                          deoxycholate (0.7 mg/kg) on alternate days if the
                                                                      creatinine clearance remains static and give as many
              Renal impairment (creatinine clearance < 50 mL/min)     doses as possible over the 2-week induction period.
              If there is renal impairment at the time of diagnosis of CM   Important practice point
              with a calculated creatinine clearance of 30 mL/min – 50 mL/
              min, the recommended induction regimens are the following:  Clinicians should be very clear when prescribing liposomal
                                                                    amphotericin B versus amphotericin B deoxycholate. The
              •  If liposomal amphotericin B is available, switch to 1 week   daily doses are different.
                 of liposomal amphotericin B (3 mg/kg/day – 4 mg/kg/
                 day) and flucytosine, followed by 1 week of fluconazole   Intravenous fluids should be administered to all patients.
                 (both fluconazole and flucytosine dose adjusted according   Tenofovir and amphotericin B deoxycholate can be used
                 to creatinine clearance) (Table 6).                together provided the patient’s renal function is normal and
              •  One week of amphotericin B deoxycholate (1 mg/kg/day)   serum creatinine does not double on treatment.  Among
                 and flucytosine (dose adjusted according to creatinine   patients with renal impairment,  ART regimens containing
                 clearance), followed by 1 week of fluconazole (dose   tenofovir should be adjusted, switching to an alternative
                 adjusted according to creatinine clearance) (Table 6).  antiretroviral agent such as abacavir. If the patient’s initial


              TABLE 5: Flucytosine dosing in children and adults with normal renal function.
              Lower weight   Upper weight   Number of   Total dose   Daily dose for lower   Daily dose for upper   Dose 1†  Dose 2†  Dose 3†  Dose 4†
              limit (kg)  limit (kg)  pills  (mg)  weight limit (mg/kg)   weight limit (mg/kg)
              20           24        4      2000       100.00         83.33       1        1         1         1
              25           29        5      2500       100.00         86.21       2        1         1         1
              30           34        6      3000       100.00         88.24       2        1         2         1
              35           39        7      3500       100.00         89.74       2        2         2         1
              40           44        8      4000       100.00         90.91       2        2         2         2
              45           49        9      4500       100.00         91.84       3        2         2         2
              50           54        10     5000       100.00         92.59       3         2        3         2
              55           59        11     5500       100.00         93.22       3         3        3         2
              60           64        12     6000       100.00         93.75       3         3        3         3
              65           69        13     6500       100.00         94.20       4         3        3         3
              70           74        14     7000       100.00         94.59       4         3        4         3
              75           79        15     7500       100.00         94.94       4        4         4         3
              80           84        16     8000       100.00         95.24       4        4         4         4
              †, Number of 500 mg pills per dose.
              TABLE 6: Induction therapy doses of flucytosine, fluconazole and amphotericin B adjusted according to estimated glomerular filtration rates for adults.
              Antifungal agent       eGFR > 50        eGFR 10–50       eGFR < 10          Haemodialysis
              Amphotericin B deoxycholate  1 mg/kg    1 mg/kg          1 mg/kg            1 mg/kg (can administer during dialysis)
              Fluconazole            1200 mg daily    600 mg daily     600 mg daily       600 mg daily; dose after dialysis
              Flucytosine            25 mg/kg 6 hourly  25 mg/kg 12 hourly  25 mg/kg daily  25 mg/kg daily; dose after dialysis
              Source: The Sanford guide to antimicrobial therapy 2019 / editors, David N. Gilbert, M.D., George M. Eliopoulos, M.D., Henry F. Chambers, M.D., Michael S. Saag, M.D., Andrew T. Pavia, M.D.
              Sperryville, VA, USA: Antimicrobial Therapy, Inc., [2019]
              Note: Multiply by 0.85 for women. Children: CrCL 20 mL/min – 40 mL/min: flucytosine 25 mg/kg q12h; 10 mL/min – 20 mL/min: flucytosine 25 mg/kg q24 h; < 10 mL/min: flucytosine 25 mg/kg
              q24–48h. Glomerular filtration rate (GFR) is a key indicator of renal function. Estimated GFR (eGFR) is a mathematically derived entity based on a patient’s serum creatinine level, age, sex and race.
              Creatinine clearance (CrCL), an estimate of GFR, can be estimated in adults using the Cockcroft–Gault equation: [[140-age (years)]*weight (kg)] / [0.8136*serum creatinine (µmol/L)].

                                           http://www.sajhivmed.org.za  14  Open Access
   16   17   18   19   20   21   22   23   24   25   26